Dr. Rodney Dalisay discusses NeuroAiD II MLC 901 in Post Stroke Recovery during an E* Chi'mes Dinner Symposium.Mar 28, 20250 min read
E* Chi'mes Pharmaceutical Inc. Presents NeuroAiD II in the Management of Mild Cognitive Impairment (MCI), Alzheimer’s Disease (AD), and Vascular Dementia (VD).
Comments